Sign In
CAVD Portal Log On
Log On Help
search
Home
The CAVD
The Research
The Grantees
About the CAVD
CAVD Structure
Collaborating Institutions
History of the CAVD
Legal Agreements
Young Investigators Recognition
About the Research
Progress in the CAVD
Publications
Conference Abstracts
Study Results
Gallo Vaccine Discovery Consortium
Greenberg Mouse Immunology Lab
Haynes Vaccine Discovery Consortium
Haynes Centralized Envelope Development Consortium
Ho Vaccine Discovery Consortium
Ho Ibalizumab Development Consortium
Koup Vaccine Immune Monitoring Consortium
Letvin Vaccine Discovery Consortium
McElrath Vaccine Discovery Consortium
Montefiori Vaccine Immune Monitoring Consortium
Pantaleo Vaccine Discovery Consortium
Pantaleo Poxvirus Vaccine Development Consortium
Parks Vaccine Discovery Consortium
Patterson Vaccine Discovery Consortium
Reinherz Vaccine Discovery Consortium
Self Vaccine Immunology Statistical Center
Stamatatos Vaccine Discovery Consortium
von Briesen HIV Specimen Cryorepository
Walker Vaccine Discovery Consortium
Weiss Vaccine Discovery Consortium
Wilson Vaccine Discovery Consortium
Zolla-Pazner Vaccine Discovery Consortium
Title
Role of HIV membrane in neutralization by two broadly neutralizing antibodies.
Primary Author
Alam, SM
Authors
Alam SM, Morelli M, Dennison SM, Liao HX, Zhang R, Xia SM, Rits-Volloch S, Sun L, Harrison SC, Haynes BF, Chen B.
CAVD Grantee
Haynes VDC
Journal Name
Proceedings of the National Academy of Sciences
Publication Date
11/11/2009
PubMed Search
Find in PubMed
Link to full-text
PNAS
PMID
19906992
Abstract
Induction of effective antibody responses against HIV-1 infection remains an elusive goal for vaccine development. Progress may require in-depth understanding of the molecular mechanisms of neutralization by monoclonal antibodies. We have analyzed the molecular actions of two rare, broadly neutralizing, human monoclonal antibodies, 4E10 and 2F5, which target the transiently exposed epitopes in the membrane proximal external region (MPER) of HIV-1 gp41 envelope during viral entry. Both have long CDR H3 loops with a hydrophobic surface facing away from the peptide epitope. We find that the hydrophobic residues of 4E10 mediate a reversible attachment to the viral membrane and that they are essential for neutralization, but not for interaction with gp41. We propose that these antibodies associate with the viral membrane in a required first step and are thereby poised to capture the transient gp41 fusion intermediate. These results bear directly on strategies for rational design of HIV-1 envelope immunogens.
Was this publication authored by individuals from more than one CAVD Consortium?
No
Collaborating Consortia
Attachments
Created at 11/29/2009 10:44 AM by Robyn Eakle
Last modified at 3/25/2010 3:43 PM by Brian Sanders
Use this page to add attachments to an item.
Name
© CAVD
Non-Member Access